The emergence of Haemophilus influenzae types e and f as significant pathogens

L A Waggoner-Fountain1, J O Hendley, E J Cody

  • 1Department of Pediatrics, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

Insights

Non-type b encapsulated Haemophilus influenzae meningitis is increasing, with types e and f identified in four children. This rise may be linked to the success of Haemophilus influenzae type b vaccination programs.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Vaccinology

Background:

  • Haemophilus influenzae type b (Hib) was historically the leading cause of bacterial meningitis in children.
  • Hib vaccines have dramatically reduced invasive Hib disease and carriage.
  • Other encapsulated serotypes of H. influenzae rarely caused invasive infections.

Observation:

  • Four cases of non-type b encapsulated Haemophilus influenzae meningitis (two type e, two type f) occurred within six months.
  • These cases were diagnosed in children at the University of Virginia.
  • Clinical presentation and treatment for non-type b meningitis mirror that of Hib meningitis.

Findings:

  • An apparent increase in invasive disease caused by non-type b encapsulated H. influenzae serotypes.
  • The observed rise in non-type b infections is potentially a consequence of reduced Hib prevalence.
  • Reduced oropharyngeal carriage of Hib may allow other serotypes to emerge.

Implications:

  • Highlights the need for continued surveillance of all encapsulated H. influenzae serotypes.
  • Suggests potential shifts in the epidemiology of bacterial meningitis post-Hib vaccination.
  • Underscores the importance of understanding the impact of vaccination on the carriage and disease spectrum of related pathogens.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...